Holen Sie sich die Stockscreener-App
34.08
2.04%
-0.71
Handel nachbörslich:
34.16
0.08
+0.23%
Schlusskurs vom Vortag:
$34.79
Offen:
$34.81
24-Stunden-Volumen:
384.16K
Relative Volume:
0.72
Marktkapitalisierung:
$1.05B
Einnahmen:
$1.37B
Nettoeinkommen (Verlust:
$47.06M
KGV:
22.49
EPS:
1.5151
Netto-Cashflow:
$150.88M
1W Leistung:
+1.76%
1M Leistung:
-14.59%
6M Leistung:
-26.66%
1J Leistung:
-39.40%
1-Tages-Spanne:
$33.82
$35.12
1-Wochen-Bereich:
$33.62
$36.27
52-Wochen-Spanne:
$33.21
$61.08
Conmed Corp Stock (CNMD) Company Profile
Firmenname
Conmed Corp
Sektor
Branche
Telefon
727-214-2974
Adresse
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
34.08 | 1.07B | 1.37B | 47.06M | 150.88M | 1.5151 |
ABT
Abbott Laboratories
|
102.30 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.30 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.28 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.59 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.19 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-06-12 | Herabstufung | Needham | Buy → Hold |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-02-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Bestätigt | Needham | Buy |
| 2023-05-22 | Eingeleitet | CL King | Buy |
| 2023-03-27 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-10-06 | Hochstufung | Needham | Hold → Buy |
| 2021-07-15 | Eingeleitet | UBS | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2019-11-26 | Herabstufung | Needham | Buy → Hold |
| 2019-11-12 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-31 | Bestätigt | Needham | Buy |
| 2019-10-04 | Bestätigt | Needham | Buy |
| 2019-08-22 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Eingeleitet | Stifel | Buy |
| 2019-04-16 | Bestätigt | Needham | Buy |
| 2019-01-23 | Bestätigt | Needham | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-08-07 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-04-26 | Bestätigt | Needham | Buy |
| 2018-02-01 | Bestätigt | Needham | Buy |
| 2017-07-27 | Bestätigt | Needham | Buy |
| 2017-04-27 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Bestätigt | Needham | Buy |
| 2016-11-18 | Bestätigt | Needham | Buy |
| 2016-07-28 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Bestätigt | Needham | Buy |
| 2015-10-22 | Bestätigt | Northland Capital | Market Perform |
Alle ansehen
Conmed Corp Aktie (CNMD) Neueste Nachrichten
CONMED Corporation (CNMD) Stock Price, News, Quote & History - Yahoo! Finance Canada
Allspring Global Investments Holdings LLC Grows Stake in CONMED Corporation $CNMD - MarketBeat
Guidance Update: Whats the analyst consensus on CONMED Corporation2026 Short Interest & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
CNMD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
CNMD SEC FilingsConmed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
CONMED (CNMD) CEO Pat Beyer awarded $1M in RSUs vesting over 3 years - Stock Titan
CONMED schedules April 29 earnings release, 4:30 p.m. call - Stock Titan
Conmed Corp (EC8.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
CNMD PE Ratio & Valuation, Is CNMD Overvalued - Intellectia AI
CONMED Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
CONMED Corp. Stock Plummets to New 52-Week Low of $34.54 - Markets Mojo
Published on: 2026-03-31 05:24:09 - baoquankhu1.vn
CONMED (NYSE:CNMD) Upgraded by Wall Street Zen to Strong-Buy Rating - marketbeat.com
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
CONMED (NYSE:CNMD) Sets New 12-Month LowTime to Sell? - marketbeat.com
Does CONMED Corporation have declining or rising EPS2026 Levels & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Conmed Corporation stock hits 52-week low at 35.34 USD - Investing.com
Responsive Playbooks and the CNMD Inflection - news.stocktradersdaily.com
Conmed Corporation stock hits 52-week low at 35.34 USD By Investing.com - Investing.com Canada
Aug Mood: What are the future prospects of CONMED Corporation2026 Technicals & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
[SCHEDULE 13G/A] CONMED Corp Amended Passive Investment Disclosure - Stock Titan
Are Options Traders Betting on a Big Move in CONMED Stock? - Yahoo Finance
Tudor Investment Corp ET AL Acquires 83,418 Shares of CONMED Corporation $CNMD - MarketBeat
Movement Recap: Can CONMED Corporation sustain its profitability2026 Technical Patterns & AI Powered Market Entry Strategies - baoquankhu1.vn
CONMED (NYSE:CNMD) Strengthens Role In Nyse Composite Landscape - Kalkine Media
Is It Time To Reassess CONMED (CNMD) After A 39% One Year Share Price Slide - simplywall.st
Market Pulse: Is CONMED Corporation likely to announce a buyback2026 Breakouts & High Accuracy Investment Signals - baoquankhu1.vn
Confluence Investment Management LLC Has $3.70 Million Stake in CONMED Corporation $CNMD - Defense World
Conmed (NYSE:CNMD) Portfolio Changes Reflect Broader Market Trends Nyse Composite Today - Kalkine Media
CONMED (NYSE:CNMD) Stock Rating Upgraded by Wells Fargo & Company - Defense World
Micro-Tech Endoscopy to acquire Conmed gastroenterology products - MassDevice
Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Alto Neuroscience, Inc. (ANRO) and Pfizer (PFE) - The Globe and Mail
CONMED (NYSE:CNMD) Upgraded to "Hold" at Wells Fargo & Company - MarketBeat
CONMED (NYSE: CNMD) EVP granted 17,198 RSUs after award correction - Stock Titan
CONMED (NYSE: CNMD) VP granted 17,471 RSUs under 2025 incentive plan - Stock Titan
CONMED (CNMD) grants 18,563 RSUs to its general counsel Foust - Stock Titan
Executive VP at CONMED (CNMD) awarded 16,926 RSUs in corrected Form 4/A - Stock Titan
[Form 4/A] CONMED Corp Amended Insider Trading Activity - Stock Titan
Micro-Tech Endoscopy Signs Definitive Agreement to Acquire Duraclip™, Precisor®, and Optibite® Product Lines from CONMED - Yahoo! Finance Canada
Piper Sandler cuts CONMED stock rating on execution issues - Investing.com
Understanding the Setup: (CNMD) and Scalable Risk - news.stocktradersdaily.com
Here's why you should retain CONMED stock in your portfolio now - MSN
CONMED (NYSE: CNMD) appoints Andrew Moller interim principal financial officer - Stock Titan
A Look At CONMED (CNMD) Valuation After Recent Weak Share Price Momentum - Yahoo Finance
CONMED (CNMD) executive exercises RSUs and updates reported share holdings - Stock Titan
Here's Why You Should Retain CONMED Stock in Your Portfolio Now - Finviz
CONMED Corp. Experiences Valuation Adjustment Amidst Competitive Market Dynamics - Markets Mojo
CONMED Corp. Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
CONMED (NYSE:CNMD) Raised to Strong-Buy at Wall Street Zen - MarketBeat
Pharma News: What hedge funds are buying CONMED Corporation2025 Momentum Check & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know - Yahoo Finance
Finanzdaten der Conmed Corp-Aktie (CNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Conmed Corp-Aktie (CNMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kaye Mark | Director |
Feb 24 '26 |
Option Exercise |
0.00 |
152 |
0 |
152 |
| Glaze Richard | Chief Information Officer |
Nov 21 '25 |
Sale |
41.21 |
257 |
10,591 |
0 |
| Glaze Richard | Chief Information Officer |
Nov 20 '25 |
Option Exercise |
0.00 |
375 |
0 |
375 |
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):